Covered recipient · General Payments record
DAVID ARNOLD
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2020–2024
$2,739.80
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $899.12 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $319.53 | 11 |
| Amgen Inc. | $177.56 | 11 |
| GENZYME CORPORATION | $153.07 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $81.01 | 3 |
| Dermavant Sciences, Inc. | $41.42 | 2 |
| Krystal Biotech Inc | $32.32 | 1 |
| E.R. Squibb & Sons, L.L.C. | $26.46 | 1 |
| Verrica Pharmaceuticals Inc. | $24.47 | 1 |
| Blueprint Medicines Corporation | $23.18 | 1 |
| Lilly USA, LLC | $20.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $85.63 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240653 | CMS |
| ABBVIE INC. | $6.85 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240655 | CMS |
| ABBVIE INC. | $30.93 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240657 | CMS |
| ABBVIE INC. | $7.80 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240659 | CMS |
| ABBVIE INC. | $3.17 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240661 | CMS |
| ABBVIE INC. | $24.35 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240663 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240665 | CMS |
| ABBVIE INC. | $122.95 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240667 | CMS |
| ABBVIE INC. | $6.74 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240669 | CMS |
| ABBVIE INC. | $0.34 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240671 | CMS |
| ABBVIE INC. | $25.87 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240673 | CMS |
| Amgen Inc. | $5.53 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192664 | CMS |
| Amgen Inc. | $27.61 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192666 | CMS |
| Amgen Inc. | $14.29 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192670 | CMS |
| Amgen Inc. | $18.86 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192672 | CMS |
| Amgen Inc. | $36.87 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192668 | CMS |
| Amgen Inc. | $6.74 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192674 | CMS |
| Amgen Inc. | $23.18 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192676 | CMS |
| Amgen Inc. | $8.29 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192678 | CMS |
| Amgen Inc. | $27.39 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192680 | CMS |
| Amgen Inc. | $0.99 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192682 | CMS |
| Amgen Inc. | $7.81 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117192684 | CMS |
| Blueprint Medicines Corporation | $23.18 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147445918 | CMS |
| Dermavant Sciences, Inc. | $13.98 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127848942 | CMS |
| Dermavant Sciences, Inc. | $27.44 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127848944 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.46 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101458669 | CMS |
| GENZYME CORPORATION | $49.88 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139603488 | CMS |
| GENZYME CORPORATION | $103.19 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139603560 | CMS |
| Krystal Biotech Inc | $32.32 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084809862 | CMS |
| Lilly USA, LLC | $20.10 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136130632 | CMS |
| Novartis Pharmaceuticals Corporation | $26.66 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086647569 | CMS |
| Novartis Pharmaceuticals Corporation | $29.59 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086647571 | CMS |
| Novartis Pharmaceuticals Corporation | $24.76 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086647573 | CMS |
| Verrica Pharmaceuticals Inc. | $24.47 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118377588 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.